Centre Hospitalier General De Bastia
- Address
- lock Available on a paid plan
Centre Hospitalier General De Bastia - Cardiovascular Research
The Centre Hospitalier General De Bastia is actively engaged in advanced cardiovascular research, with a particular focus on innovative therapeutic approaches for acute myocarditis and heart failure management. The center specializes in evaluating novel treatment strategies for patients with cardiac inflammatory conditions and associated ventricular dysfunction.
- Corticosteroid therapy protocols for acute myocarditis with left ventricular dysfunction
- Advanced cardiac imaging including cardiac magnetic resonance imaging (CMRi) for myocardial disease diagnosis
- Long-term cardiovascular outcomes assessment and prevention of major adverse cardiac events
The center's research program emphasizes evidence-based approaches to managing acute myocarditis, utilizing sophisticated diagnostic tools such as endomyocardial biopsy and CMRi. Their clinical investigations focus on evaluating the efficacy of immunosuppressive therapies in conjunction with conventional heart failure treatment, with comprehensive assessment of cardiac function through measurements of left ventricular ejection fraction (LVEF) and Global Longitudinal Strain (GLS) over extended follow-up periods.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centre Hospitalier General De Bastia
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Methylprednisolone and Prednisone in Acute Myocarditis with Severe Left Ventricular Dysfunction: A Multicenter Randomized Controlled Trial | Assistance Publique Hopitaux De Paris | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 13 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Anakinra | 1 | Unknown | 2026-07-09 | 2026-07-09 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.